BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26392361)

  • 1. Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.
    Duffour J; Combes A; Crapez E; Boissière-Michot F; Bibeau F; Senesse P; Ychou M; Courraud J; de Forges H; Roca L
    J Genet Couns; 2016 Jun; 25(3):432-42. PubMed ID: 26392361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.
    Dewanwala A; Chittenden A; Rosenblatt M; Mercado R; Garber JE; Syngal S; Stoffel EM
    Fam Cancer; 2011 Sep; 10(3):549-56. PubMed ID: 21567236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
    Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.
    Aktan-Collan K; Haukkala A; Mecklin JP; Uutela A; Kääriäinen H
    Int J Cancer; 2001 Aug; 93(4):608-11. PubMed ID: 11477567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
    Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
    J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma.
    Murakami Y; Okamura H; Sugano K; Yoshida T; Kazuma K; Akechi T; Uchitomi Y
    Cancer; 2004 Jul; 101(2):395-403. PubMed ID: 15241839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in saliva from patients with hereditary non-polyposis colon cancer and siblings carrying germline mismatch repair gene mutations.
    Hu P; Lee CW; Xu JP; Simien C; Fan CL; Tam M; Ramagli L; Brown BW; Lynch P; Frazier ML; Siciliano MJ; Coolbaugh-Murphy M
    Ann Clin Lab Sci; 2011; 41(4):321-30. PubMed ID: 22166501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
    Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
    J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?
    Maccaroni E; Bracci R; Giampieri R; Bianchi F; Belvederesi L; Brugiati C; Pagliaretta S; Del Prete M; Scartozzi M; Cascinu S
    Oncotarget; 2015 Nov; 6(36):38737-48. PubMed ID: 26485756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM
    Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A
    Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.